View Clinical Trial (Medical Research Study)
Anesthetic Effect of Lidocaine/Epinephrine Solution Delivered Via Iontophoresis to External Auditory Apparatus - NCT00941993-30309(Clinical Trial 302665)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Atlanta |
|
State:
|
|
GA |
| Zip Code: |
|
30309 |
| Conditions: |
|
Acute Otitis Media - Chronic Otitis Media - Recurrent Acute Otitis Media |
| Purpose: |
|
This is a non-randomized, multi-center, prospective, clinical study intended to evaluate the
effectiveness of a method for iontophoretic delivery of a buffered lidocaine/epinephrine
solution for provision of tympanic membrane anesthesia in patients who are indicated for
local anesthetic procedures requiring penetration of the tympanic membrane, including, but
not limited to, myringtomy, tympanocentesis with culture or tympanostomy with tube
placement.
|
| Study summary: |
|
The effectiveness of the anesthetic method will be assessed by the investigator after
completion of iontophoresis delivery and within 5 minutes of removing the system. Patients
will also be asked to rate the effectiveness of the anesthetic method after the completion
of the indicated ear procedure (before any suction is performed), using a pain scale such as
the Wong-Baker Faces Pain Scale. |
| Criteria: |
|
Inclusion Criteria:
1. Age 12 months and older
2. Both male and female patients eligible
3. Patients are indicated for procedures requiring penetration of the tympanic membrane
(including, but not limited to, myringotomy, tympanocentesis with culture or
tympanostomy with tube implant)
Exclusion Criteria:
1. Patients with a history of sensitivity or reaction to lidocaine, epinephrine or any
hypersensitivity to local anesthetics of the amide type or any component of the drug
solution
2. Markedly atrophic, retracted, atelectatic or perforated tympanic membrane
3. Otitis externa
4. Electrically sensitive patients and patients with electrically sensitive support
systems (pacemakers, defibrillators, etc.)
5. Damaged or denuded skin in the auditory canal
6. Cerumen impaction resulting in a significant amount of cleaning required to visualize
the tympanic membrane |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 17, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|